Hirsutism: Clinical Trials

5 trials for Hirsutism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Hirsutism: new trials by email Literature Review of Hirsutism trials Research Report on Hirsutism

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome
Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the s, Placebo - PCO - Polycystic Ovaries, Obesity and Obesity-related Medical Conditions
Phase 1RecruitingIsfahan University of Medical Sciences442024-07-222024-10-17
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
FOL-005, Placebo - Hypertrichosis, Alopecia
Phase 1 / Phase 2CompletedFollicum AB442016-01-012017-08-01
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA), Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA) - Prostate Cancer, Hirsutism
Phase 1CompletedSandoz362006-08-012017-03-28
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA), Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA) - Prostate Cancer, Hirsutism
Phase 1CompletedSandoz362006-06-012017-03-28
Photodynamic Therapy for Permanent Hair Removal
application of a dye suspension followed by a laser intervention - Hypertrichosis, Hirsutism
Phase 1 / Phase 2UnknownUniversity of Jena2008-06-04

Narrower conditions

Hypertrichosis (2)  ·  Prostatic Neoplasms (2)  ·  Alopecia (1)  ·  Obesity (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Hair Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Virilism (5)  ·  Genital Diseases (3)  ·  Neoplasms (3)  ·  Urogenital Diseases (3)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

bicalutamide (2)

Sponsors

Sandoz (2)  ·  Follicum AB (1)  ·  Isfahan University of Medical Sciences (1)  ·  University of Jena (1)

Countries

Germany (2)  ·  Iran (1)

Top investigators

Richard Larouche, M.D. (2)  ·  Martin Kaatz, Dr (1)  ·  Nafiseh Shokri-Mashhadi, Dr. (1)  ·  Ulrike Blume-Peytavi, Professor (1)